These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 7729640

  • 1. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid.
    Vuoristo M, Färkkilä M, Karvonen AL, Leino R, Lehtola J, Mäkinen J, Mattila J, Friman C, Seppälä K, Tuominen J.
    Gastroenterology; 1995 May; 108(5):1470-8. PubMed ID: 7729640
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE, Huet PM, Poupon R, Bonnand AM, Nhieu JT, Zafrani ES.
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [Abstract] [Full Text] [Related]

  • 3. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.
    Poupon RE, Eschwège E, Poupon R.
    J Hepatol; 1990 Jul; 11(1):16-21. PubMed ID: 1975819
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE, Balkau B, Eschwège E, Poupon R.
    N Engl J Med; 1991 May 30; 324(22):1548-54. PubMed ID: 1674105
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis.
    Almasio PL, Floreani A, Chiaramonte M, Provenzano G, Battezzati P, Crosignani A, Podda M, Todros L, Rosina F, Saccoccio G, Manenti F, Ballardini G, Bianchi FP, Scheuer PJ, Davies SE, Craxì A.
    Aliment Pharmacol Ther; 2000 Dec 30; 14(12):1645-52. PubMed ID: 11121914
    [Abstract] [Full Text] [Related]

  • 10. Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis.
    Verma A, Jazrawi RP, Ahmed HA, Davis T, Bland JM, Benson M, Orchard RT, Theodossi A, Maxwell JD, Northfield TC.
    Eur J Gastroenterol Hepatol; 1999 Oct 30; 11(10):1069-76. PubMed ID: 10524634
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine.
    Miettinen TA, Färkkilä M, Vuoristo M, Karvonen AL, Leino R, Lehtola J, Friman C, Seppälä K, Tuominen J.
    Hepatology; 1995 May 30; 21(5):1261-8. PubMed ID: 7737632
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study.
    Ikeda T, Tozuka S, Noguchi O, Kobayashi F, Sakamoto S, Marumo F, Sato C.
    J Hepatol; 1996 Jan 30; 24(1):88-94. PubMed ID: 8834030
    [Abstract] [Full Text] [Related]

  • 19. [Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].
    Raedsch R, Stiehl A, Walker S, Scherrmann JM, Kommerell B.
    Z Gastroenterol; 1992 Mar 30; 30 Suppl 1():55-7. PubMed ID: 1449019
    [Abstract] [Full Text] [Related]

  • 20. A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA.
    Hirschfield GM, Beuers U, Kupcinskas L, Ott P, Bergquist A, Färkkilä M, Manns MP, Parés A, Spengler U, Stiess M, Greinwald R, Pröls M, Wendum D, Drebber U, Poupon R.
    J Hepatol; 2021 Feb 30; 74(2):321-329. PubMed ID: 32950590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.